Exchange: NASDAQ·Updated 09:44 AM EDT
OPT logo

OPTOpthea Limited - ADR

$0.022
$0.0048
(27.91%)
Today
Reported EarningsFeb 27
Mkt Cap$3.76M
Vol400.00

About

Ceryvyn Therapeutics Ltd. is a clinical stage biopharmaceutical company, which engages in the development and research of novel therapeutic products based on targeting Vascular Endothelial Growth Factors. It operates through the United States and Australia geographical segments. The company was founded by Dr. Megan Baldwin on October 17, 1984, and is headquartered in Melbourne, Australia.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Ceryvyn Therapeutics Ltd. - ADR?
What is the 52-week high for Ceryvyn Therapeutics Ltd. - ADR?
What is the 52-week low for Ceryvyn Therapeutics Ltd. - ADR?
What is Ceryvyn Therapeutics Ltd. - ADR stock price today?
What was Ceryvyn Therapeutics Ltd. - ADR stock price yesterday?
What is the PE ratio of Ceryvyn Therapeutics Ltd. - ADR?
What is the Price-to-Book ratio of Ceryvyn Therapeutics Ltd. - ADR?
What is the 50-day moving average of Ceryvyn Therapeutics Ltd. - ADR?

Advertisement|Remove ads.